RAPT Therapeutics Inc (RAPT) stock news · $132.1M cap
RAPT Therapeutics Inc (RAPT) is a biotechnology company listed on US.
This RAPT news page leads with what RAPT Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for RAPT yet. We will not pad this page with generic market recap.
Latest reported RAPT revenue for 2023-12-31 was $0. Net income was -$116.8M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. RAPT currently screens at market cap $132.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the RAPT stock page; for the tape open the quote page.
RAPT stock news FAQ
What is RAPT's latest net income?
Latest cached RAPT Therapeutics Inc (RAPT) net income was -$116.8M. Statements: https://lician.com/financials/rapt
What is RAPT's market cap?
RAPT Therapeutics Inc (RAPT) market cap is $132.1M on the latest cached fundamentals snapshot.
What kind of company is RAPT?
RAPT Therapeutics Inc (RAPT) is a biotechnology company listed on US.
Where is RAPT stock news listed?
Cached stock news for RAPT Therapeutics Inc (RAPT) is listed at https://lician.com/news/rapt. Filings: https://lician.com/sec/rapt
Not investment advice.